SNGX
Soligenix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.38
−0.84%Aug 7, 2026, 11:30 UTC
Soligenix announced its financial results for the quarter ended June 30, 2026.
Source:Jun 12, 2026, 00:00 UTC
Richard C. Straube retired as Chief Medical Officer and Senior Vice President of Soligenix, Inc., effective August 12, 2025.